Linked cyclic polyamines with activity against hiv.
申请人:AnorMED Inc.
公开号:EP1223166A1
公开(公告)日:2002-07-17
There is disclosed a pharmaceutical composition comprising as active ingredient a linked cyclic compound of general formula I,
Z - R - A - R' - Y (I)
in which Z and Y are independently cyclic polyamine moieties having from 9 to 32 ring members and from 3 to 8 amine nitrogens in the ring spaced by 2 or more carbon atoms from each other,
A is an aromatic or heteroaromatic moiety,
R and R' are each a substituted or unsubstituted alkylene chain or heteroatom containing chain.
or an acid addition salt or metal complex thereof, in admixture or association with a pharmaceutically acceptable diluent or carrier.
Synthesis and Structure-Activity Relationships of Phenylenebis(methylene)-Linked Bis-Tetraazamacrocycles That Inhibit HIV Replication. Effects of Macrocyclic Ring Size and Substituents on the Aromatic Linker
作者:Gary J. Bridger、Renato T. Skerlj、David Thornton、Sreenivasan Padmanabhan、Stephen A. Martellucci、Geoffrey W. Henson、Michael J. Abrams、Naohiko Yamamoto、Karen De Vreese
DOI:10.1021/jm00002a019
日期:1995.1
macrocyclic ring size was varied from 12 to 16 ring members. Depending upon the substitution of the phenylenebis(methylene) linker (para or meta), sub-micromolar anti-HIV activity was exhibited by analogs bearing macrocycles of 12-14 ring members but with varying cytotoxicity to MT-4 cells. Furthermore, while we found that identical macrocyclic rings are not required for activity, substituting an acyclic